TORONTO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Ninepoint Partners LP ("Ninepoint Partners”) today announced the final November ...

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline ...

Windtree Therapeutics, Inc. ("Windtree" or "the Company") (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative ...

Sydney, Australia, 28 November 2024 – Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, has completed one of the largest Series A ...

Sydney-based biotechnology company Celosia Therapeutics has secured $16.75 million in Series A funding to advance its ...

The government grant is less than originally expected because the chip giant is also receiving separate funding for ...

Lou Basenese, chief market strategist at Public Ventures LLC, spoke with Quartz for the latest installment of our “Smart ...

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...

Cradle raised $73 million in a Series-B investment round. With this, the biotech startup aims to invest heavily in its own AI ...

Adcendo joins a growing group of biotechs working to usher the next generation of antibody-drug conjugates to the market.

Adcendo is adding $135 million to its arsenal, money that will go toward launching several antibody-drug conjugate (ADC) ...

Genus Phytophthora threat various plant species including fruit, vegetable, and flower crops. The authors report that some NLRs recognize conserved effector families of multiple Phytophthora ...